Immutep Limited
PRRUF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $5,044 | $3,842 | $3,506 | $170 |
| % Growth | 31.3% | 9.6% | 1,957.7% | – |
| Cost of Goods Sold | $61,411 | $41,547 | $2,062 | $31,342 |
| Gross Profit | -$56,367 | -$37,705 | $1,444 | -$26,627 |
| % Margin | -1,117.6% | -981.4% | 41.2% | -15,629.1% |
| R&D Expenses | $61,411 | $41,547 | $28,793 | $25,338 |
| G&A Expenses | $8,645 | $8,853 | $8,680 | $7,210 |
| SG&A Expenses | $8,645 | $8,853 | $14,082 | $7,210 |
| Sales & Mktg Exp. | $0 | $0 | $5,402 | $0 |
| Other Operating Expenses | $0 | $0 | $2,062 | $0 |
| Operating Expenses | $70,055 | $50,399 | $44,937 | $32,548 |
| Operating Income | -$126,422 | -$88,104 | -$77,688 | -$33,938 |
| % Margin | -2,506.5% | -2,293.3% | -2,216% | -19,920% |
| Other Income/Exp. Net | $64,988 | $45,388 | $37,792 | $1,627 |
| Pre-Tax Income | -$61,434 | -$42,717 | -$39,896 | -$32,211 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$61,434 | -$42,717 | -$39,896 | -$32,211 |
| % Margin | -1,218% | -1,111.9% | -1,138% | -18,906.5% |
| EPS | -0.042 | -0.036 | -0.044 | -0.037 |
| % Growth | -18.5% | 19.6% | -18.4% | – |
| EPS Diluted | -0.042 | -0.036 | -0.044 | -0.037 |
| Weighted Avg Shares Out | 1,455,820 | 1,199,905 | 900,641 | 862,338 |
| Weighted Avg Shares Out Dil | 1,455,818 | 1,201,062 | 900,641 | 862,338 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5,250 | $3,883 | $939 | $225 |
| Interest Expense | $0 | $31 | $20 | $92 |
| Depreciation & Amortization | $2,134 | $2,013 | $1,859 | $2,063 |
| EBITDA | -$62,877 | -$44,544 | -$39,572 | -$31,874 |
| % Margin | -1,246.6% | -1,159.4% | -1,128.8% | -18,708.9% |